‘You’ll never find what you’re not looking for’: NASH – under-diagnosed and under-treated

Diabetes Treatments During COVID-19

Amputations have increased 30% among diabetic patients since the pandemic began.

with Stefan Bornstein, MD

New Treatments for Diabetes 

There is concern over whether or not patients are adhering to their treatment during the pandemic.

with Kausik Ray, MD

CGM may be useful tool for tailoring 'precision diets' to improve cardiometabolic health

Optimizing Diabetes Treatment with SGLT2 Inhibitors

with Francesco Girgino, MD, PhD

The Future of Diabetes Treatments

with Gerald Shulman, MD, PhD

​

Solving the Mystery of Insulin Resistance

with Gerald Shulman, MD, PhD

​

Experts debate CV benefit of type 2 diabetes drugs for adults with type 1

Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions

Recent insulin advancements improve diabetes management

Glucose management may improve COVID-19 outcomes in diabetes

Dr Paril Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic

Guidance for bariatric surgery during, beyond COVID-19

Two New Lipid Management Treatments Emerging

with Kausik Ray, MD

Diabetes Patients Struggle with COVID-19 Infections

with Stefan Bornstein, MD

Early initiation of menopausal HT reduces all-cause mortality, CHD events in women

Virtual insulin resistance meeting highlights cardiometabolic care, COVID-19

Yehuda Handelsman, MD: The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease Preview